METHODS OF USING GENETIC VARIANTS IN THE LIPOPROTEIN LIPASE GENE TO DETERMINE LIVER ENZYME LEVELS AND INSULIN RESISTANCE

摘要

The invention relates to methods of diagnosing and/or predicting susceptibility to metabolic syndrome and associated traits by determining the presence or absence of genetic variants at the lipoprotein lipase (LPL) gene. In one embodiment, the invention provides a method of diagnosing and/or predicting susceptibility to liver enzyme levels by determining the presence or absence of LPL genetic variants.